Neurofeedback for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials
Objective - We performed meta-analyses of randomized controlled trials to examine the effects of neurofeedback on attention-deficit/hyperactivity disorder (ADHD) symptoms and neuropsychological deficits in children and adolescents with ADHD. - Method - We searched PubMed, Ovid, Web of Science, ERIC,...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
June 2016
|
| In: |
Journal of the American Academy of Child and Adolescent Psychiatry
Year: 2016, Volume: 55, Issue: 6, Pages: 444-455 |
| ISSN: | 1527-5418 |
| DOI: | 10.1016/j.jaac.2016.03.007 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1016/j.jaac.2016.03.007 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0890856716300958 
|
| Author Notes: | Samuele Cortese,MD, PhD; Maite Ferrin, MD, PhD; Daniel Brandeis, PhD; Martin Holtmann, MD; Pascal Aggensteiner, MA; David Daley, PhD; Paramala Santosh, MD, PhD; Emily Simonoff, MD, PhD; Jim Stevenson, PhD; Argyris Stringaris, MD, PhD, MRCPsych; Edmund J.S. Sonuga-Barke, PhD; on behalf of the European ADHD Guidelines Group (EAGG) |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1667502689 | ||
| 003 | DE-627 | ||
| 005 | 20240323101138.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190617s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaac.2016.03.007 |2 doi | |
| 035 | |a (DE-627)1667502689 | ||
| 035 | |a (DE-599)KXP1667502689 | ||
| 035 | |a (OCoLC)1341228101 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Cortese, Samuele |e VerfasserIn |0 (DE-588)1140449958 |0 (DE-627)898461936 |0 (DE-576)493779795 |4 aut | |
| 245 | 1 | 0 | |a Neurofeedback for attention-deficit/hyperactivity disorder |b meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials |c Samuele Cortese,MD, PhD; Maite Ferrin, MD, PhD; Daniel Brandeis, PhD; Martin Holtmann, MD; Pascal Aggensteiner, MA; David Daley, PhD; Paramala Santosh, MD, PhD; Emily Simonoff, MD, PhD; Jim Stevenson, PhD; Argyris Stringaris, MD, PhD, MRCPsych; Edmund J.S. Sonuga-Barke, PhD; on behalf of the European ADHD Guidelines Group (EAGG) |
| 264 | 1 | |c June 2016 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.06.2019 | ||
| 520 | |a Objective - We performed meta-analyses of randomized controlled trials to examine the effects of neurofeedback on attention-deficit/hyperactivity disorder (ADHD) symptoms and neuropsychological deficits in children and adolescents with ADHD. - Method - We searched PubMed, Ovid, Web of Science, ERIC, and CINAHAL through August 30, 2015. Random-effects models were employed. Studies were evaluated with the Cochrane Risk of Bias tool. - Results - We included 13 trials (520 participants with ADHD). Significant effects were found on ADHD symptoms rated by assessors most proximal to the treatment setting, that is, the least blinded outcome measure (standardized mean difference [SMD]: ADHD total symptoms = 0.35, 95% CI = 0.11-0.59; inattention = 0.36, 95% CI = 0.09-0.63; hyperactivity/impulsivity = 0.26, 95% CI = 0.08-0.43). Effects were not significant when probably blinded ratings were the outcome or in trials with active/sham controls. Results were similar when only frequency band training trials, the most common neurofeedback approach, were analyzed separately. Effects on laboratory measures of inhibition (SMD = 0.30, 95% CI = -0.10 to 0.70) and attention (SMD = 0.13, 95% CI = -0.09 to 0.36) were not significant. Only 4 studies directly assessed whether learning occurred after neurofeedback training. The risk of bias was unclear for many Cochrane Risk of Bias domains in most studies. - Conclusion - Evidence from well-controlled trials with probably blinded outcomes currently fails to support neurofeedback as an effective treatment for ADHD. Future efforts should focus on implementing standard neurofeedback protocols, ensuring learning, and optimizing clinically relevant transfer. | ||
| 650 | 4 | |a ADHD | |
| 650 | 4 | |a meta-analysis | |
| 650 | 4 | |a neurofeedback | |
| 650 | 4 | |a nonpharmacological treatment | |
| 650 | 4 | |a risk of bias | |
| 700 | 1 | |a Brandeis, Daniel |e VerfasserIn |0 (DE-588)1028379153 |0 (DE-627)730634477 |0 (DE-576)375917896 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a American Academy of Child and Adolescent Psychiatry |t Journal of the American Academy of Child and Adolescent Psychiatry |d Kidlington [u.a.] : Elsevier, 1987 |g 55(2016), 6, Seite 444-455 |h Online-Ressource |w (DE-627)32061638X |w (DE-600)2022051-0 |w (DE-576)094402027 |x 1527-5418 |7 nnas |
| 773 | 1 | 8 | |g volume:55 |g year:2016 |g number:6 |g pages:444-455 |g extent:12 |a Neurofeedback for attention-deficit/hyperactivity disorder meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jaac.2016.03.007 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0890856716300958 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190617 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1028379153 |a Brandeis, Daniel |m 1028379153:Brandeis, Daniel |d 60000 |e 60000PB1028379153 |k 0/60000/ |p 3 | ||
| 999 | |a KXP-PPN1667502689 |e 3487839466 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 17.06.2019"],"id":{"doi":["10.1016/j.jaac.2016.03.007"],"eki":["1667502689"]},"relHost":[{"id":{"issn":["1527-5418"],"zdb":["2022051-0"],"eki":["32061638X"]},"note":["Gesehen am 15.01.20"],"recId":"32061638X","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"American Academy of Child and Adolescent PsychiatryJournal of the American Academy of Child and Adolescent Psychiatry","physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"12","volume":"55","year":"2016","pages":"444-455","text":"55(2016), 6, Seite 444-455","issue":"6"},"language":["eng"],"corporate":[{"display":"American Academy of Child and Adolescent Psychiatry","role":"aut","roleDisplay":"VerfasserIn"}],"origin":[{"dateIssuedDisp":"1987-","publisher":"Elsevier ; Lippincott, Williams & Wilkins","publisherPlace":"Kidlington [u.a.] ; Philadelphia, Pa. [u.a.]","dateIssuedKey":"1987"}],"title":[{"subtitle":"JAACAP","title_sort":"Journal of the American Academy of Child and Adolescent Psychiatry","title":"Journal of the American Academy of Child and Adolescent Psychiatry"}],"titleAlt":[{"title":"JAACAP"}],"pubHistory":["26.1987 -"]}],"name":{"displayForm":["Samuele Cortese,MD, PhD; Maite Ferrin, MD, PhD; Daniel Brandeis, PhD; Martin Holtmann, MD; Pascal Aggensteiner, MA; David Daley, PhD; Paramala Santosh, MD, PhD; Emily Simonoff, MD, PhD; Jim Stevenson, PhD; Argyris Stringaris, MD, PhD, MRCPsych; Edmund J.S. Sonuga-Barke, PhD; on behalf of the European ADHD Guidelines Group (EAGG)"]},"recId":"1667502689","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"June 2016","dateIssuedKey":"2016"}],"person":[{"roleDisplay":"VerfasserIn","given":"Samuele","role":"aut","family":"Cortese","display":"Cortese, Samuele"},{"given":"Daniel","roleDisplay":"VerfasserIn","role":"aut","family":"Brandeis","display":"Brandeis, Daniel"}],"physDesc":[{"extent":"12 S."}],"title":[{"title":"Neurofeedback for attention-deficit/hyperactivity disorder","title_sort":"Neurofeedback for attention-deficit/hyperactivity disorder","subtitle":"meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials"}]} | ||
| SRT | |a CORTESESAMNEUROFEEDB2016 | ||